CD30 specific recombinant human antibodies and immunoRNases are produced in high levels using mammalian cell lines. Antibodies as well as immunoRNases mediate inhibitory effects on Hodgkin lymphoma cell lines but immunoRNases show higher efficacy.
BiopharmaImmunology